Bristol-Myers Squibb Company
US · LEI HLYYNH7UQUORYSJQCN42 · Figures of the company
Bristol-Myers Squibb Company: 8 links from the documents of the companies and the register.
Customers 3
| Entity | Figure | Evidence | Documents |
|---|---|---|---|
| McKesson Corporation | 36% of the revenue of the supplier, fiscal year ended 31 Dec 2025 | Stated | Form 10-K for the fiscal year ended 31 December 2025 |
| Cencora, Inc. | 29% of the revenue of the supplier, fiscal year ended 31 Dec 2025 | Stated | Form 10-K for the fiscal year ended 31 December 2025 |
| Cardinal Health, Inc. | 22% of the revenue of the supplier, fiscal year ended 31 Dec 2025 | Stated | Form 10-K for the fiscal year ended 31 December 2025 |
Holdings 4
| Entity | Figure | Evidence | Documents |
|---|---|---|---|
| Bristol-Myers Squibb GmbH & Co. KGaA | Consolidates the entity | Register | Record of Bristol-Myers Squibb GmbH & Co. KGaA in the register of legal entities, 4 November 2026 |
| Bristol-Myers Squibb Holdings Germany Verwaltungs GmbH | Consolidates the entity | Register | Record of Bristol-Myers Squibb Holdings Germany Verwaltungs GmbH in the register of legal entities, 4 November 2026 |
| Bristol-Myers Squibb India Private Limited | Consolidates the entity | Register | Record of BRISTOL-MYERS SQUIBB INDIA PRIVATE LIMITED in the register of legal entities, 4 November 2026 |
| Bristol-Myers Squibb International Company Unlimited Company | Consolidates the entity | Register | Record of BRISTOL-MYERS SQUIBB INTERNATIONAL COMPANY UNLIMITED COMPANY in the register of legal entities, 4 November 2026 |
Partners 1
| Entity | Figure | Evidence | Documents |
|---|---|---|---|
| Merck & Co., Inc. | Collaboration revenue of $525m, fiscal year ended 31 Dec 2025 | Stated | Form 10-K for the fiscal year ended 31 December 2025 |
Each link names the documents that state it, with the class of its evidence: stated by one party, confirmed by both, or stated by the register of legal entities. A commitment is the commitment at the date of the agreement.